申万菱信中证申万医药生物指数(LOF)C(015176)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
19,033,393.91 |
结算备付金 |
6,897.80 |
18,519.86 |
3,383.64 |
24,052.95 |
存出保证金 |
8,557.88 |
10,982.40 |
7,369.35 |
11,886.48 |
交易性金融资产 |
210,793,204.01 |
206,300,063.09 |
250,090,240.77 |
260,364,382.56 |
其中:股票投资 |
210,793,204.01 |
206,300,063.09 |
250,090,240.77 |
260,364,382.56 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
121,529.05 |
- |
- |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
252,196.17 |
247,264.26 |
273,583.18 |
442,265.65 |
其他资产 |
- |
- |
- |
- |
资产总计 |
226,428,456.27 |
221,916,611.03 |
267,882,431.57 |
279,875,981.55 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
- |
377,164.20 |
- |
371,609.25 |
应付赎回款 |
651,146.51 |
235,132.91 |
562,656.91 |
571,467.23 |
应付管理人报酬 |
200,402.84 |
189,712.56 |
227,207.60 |
231,278.37 |
应付托管费 |
40,080.55 |
37,942.50 |
45,441.49 |
50,881.24 |
应付销售服务费 |
7,357.30 |
7,080.66 |
9,184.54 |
9,464.90 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
193,558.09 |
145,970.77 |
232,322.87 |
167,032.61 |
负债合计 |
1,092,545.29 |
993,003.60 |
1,076,813.41 |
1,401,733.60 |
所有者权益 |
实收基金 |
242,608,493.72 |
256,414,847.49 |
254,249,063.63 |
254,703,265.07 |
未分配利润 |
-17,272,582.74 |
-35,491,240.06 |
12,556,554.53 |
23,770,982.88 |
所有者权益合计 |
225,335,910.98 |
220,923,607.43 |
266,805,618.16 |
278,474,247.95 |
负债及所有者权益总计 |
226,428,456.27 |
221,916,611.03 |
267,882,431.57 |
279,875,981.55 |